Mark E. Green bought Acasti Pharma, Inc. - Class A (ACST) [ST] F IlING S TATuS : New (ACST)
Mark E. Green (R-TN), a U.S. Representative, has disclosed 1 trade in Acasti Pharma, Inc. - Class A (ACST) [ST] F IlING S TATuS : New (ACST) since 2021, a single purchase, worth an estimated $8K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a purchase: Mark E. Green bought $1,001 - $15,000 of Acasti Pharma, Inc. - Class A (ACST) [ST] F IlING S TATuS : New (ACST) on March 16, 2021. Since that trade, ACST is down -20.88% against the S&P 500 up +97.92%, an outperformance of -118.80%.
Data updated
Mark E. Green's ACST trades vs the price
ACST is down -20.88% since Mark E. Green bought on March 16, 2021, versus +97.92% for the S&P 500.
Performance since this trade
All Mark E. Green ACST trades
Mark E. Green & ACST trading FAQ
Is it legal for Mark E. Green to trade Acasti Pharma, Inc. - Class A (ACST) [ST] F IlING S TATuS : New (ACST) stock?
Yes. Members of Congress are allowed to trade individual stocks, including Acasti Pharma, Inc. - Class A (ACST) [ST] F IlING S TATuS : New (ACST), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did Mark E. Green buy ACST?
Mark E. Green disclosed a purchase of $1,001 - $15,000 of Acasti Pharma, Inc. - Class A (ACST) [ST] F IlING S TATuS : New (ACST) on March 16, 2021, according to public STOCK Act filings.
How has ACST performed since Mark E. Green's trade?
Since Mark E. Green bought ACST on March 16, 2021, the stock is down -20.88%, versus +97.92% for the S&P 500 over the same period, an outperformance of -118.80%.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional ACST trades?
Quantellect tracks every disclosed congressional trade in Acasti Pharma, Inc. - Class A (ACST) [ST] F IlING S TATuS : New (ACST) on the Acasti Pharma, Inc. - Class A (ACST) [ST] F IlING S TATuS : New congressional trading page, which aggregates filings across all members of Congress.
Mark E. Green's ACST tradesAll congressional filings for Acasti Pharma, Inc. - Class A (ACST) [ST] F IlING S TATuS : NewMark E. Green's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.